Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,730
Total Claims
$677K
Drug Cost
447
Beneficiaries
$1,514
Cost/Patient
Risk Score Breakdown 18/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
-65%
Opioid rate vs peers
0.9% vs 2.5% avg
+34%
Cost per patient vs peers
$1,514 vs $1,128 avg
+58%
Brand preference vs peers
13.2% vs 8.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.9%
Opioid Rate
75
Opioid Claims
$1,198
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,148 claims · $533K
Generic: 7,519 claims · $143K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 51 | $47K |
| Empaglifloz/Linaglip/Metformin | 49 | $41K |
| Sitagliptin Phosphate | 35 | $41K |
| Linagliptin | 37 | $36K |
| Insulin Glargine,hum.Rec.Anlog | 52 | $31K |
| Empagliflozin | 40 | $30K |
| Levothyroxine Sodium | 305 | $26K |
| Dulaglutide | 25 | $24K |
| Raltegravir Potassium | 12 | $23K |
| Sitagliptin Phos/Metformin Hcl | 22 | $23K |
| Dapagliflozin Propanediol | 17 | $22K |
| Rivaroxaban | 20 | $18K |
| Linagliptin/Metformin Hcl | 13 | $16K |
| Candesartan/Hydrochlorothiazid | 75 | $16K |
| Empagliflozin/Linagliptin | 16 | $15K |
Prescribing Profile
Patient Profile
73
Avg Age
61%
Female
1.33
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data